Halozyme Therapeutics, Inc.

SUSQUEHANNA INTERNATIONAL GROUP, LLP HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

61,706

Value ($000)

4,153

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	4,153	0.0%	61,706	12/31/2025
2025 Q3	11/14/2025	533	0.0%	7,265	9/30/2025
2025 Q2	8/14/2025	9,490	0.0%	182,424	6/30/2025
2025 Q1	5/14/2025	10,353	0.0%	162,245	3/31/2025
2024 Q4	2/14/2025	4,524	0.0%	94,619	12/31/2024
2024 Q3	11/14/2024	5,451	0.0%	95,227	9/30/2024
2024 Q2	8/15/2024	2,003	0.0%	38,259	6/30/2024
2024 Q1	5/7/2024	2,475	0.0%	60,833	3/31/2024
2023 Q4	2/14/2024	2,994	0.0%	81,015	12/31/2023
2023 Q3	11/14/2023	4,198	0.0%	109,886	9/30/2023
2023 Q2	8/11/2023	4,235	0.0%	117,410	6/30/2023
2023 Q1	5/16/2023	6,218	0.0%	162,826	3/31/2023
2022 Q4	2/14/2023	5,318	0.0%	93,458	12/31/2022
2022 Q3	11/14/2022	6,948	0.0%	175,743	9/30/2022
2022 Q2	8/15/2022	4,239	0.0%	96,331	6/30/2022
2022 Q1	5/16/2022	2,093	0.0%	52,490	3/31/2022
2021 Q4	2/14/2022	5,575	0.0%	138,628	12/31/2021
2021 Q3	11/15/2021	3,194	0.0%	78,531	9/30/2021
2021 Q2	8/11/2021	1,019	0.0%	22,444	6/30/2021
2021 Q1	5/17/2021	1,819	0.0%	43,640	3/31/2021
2020 Q4	2/16/2021	1,173	0.0%	27,466	12/31/2020
2020 Q3	11/16/2020	1,043	0.0%	39,670	9/30/2020
2020 Q2	8/14/2020	2,871	0.0%	107,088	6/30/2020
2020 Q1	5/15/2020	1,163	0.0%	64,666	3/31/2020
2019 Q4	2/14/2020	1,783	0.0%	100,558	12/31/2019
2014 Q1	5/14/2014	4,070	0.0%	320,369	3/31/2014
2013 Q4	2/13/2014	6,038	0.0%	402,768	12/31/2013